Evidence map›Paper›PMID 35026727›Full record

ArticleThe American journal of tropical medicine and hygiene2022

A Novel Malaria Lateral Flow Assay for Detecting Plasmodium falciparum Lactate Dehydrogenase in Busia, Uganda.

Christine M Bachman, David M Cate, Ben Grant, Stephen Burkot, Jerry Mulondo, Helen V Hsieh, Martin Chamai, Bakar Odongo, Peter Olwoch, Mayimuna Nalubega and 6 more

Open access · hybridAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Christine M BachmanGlobal Health Laboratories, Bellevue, Washington.
David M CateGlobal Health Laboratories, Bellevue, Washington.
Ben GrantGlobal Health Laboratories, Bellevue, Washington.
Stephen BurkotGlobal Health Laboratories, Bellevue, Washington.
Jerry MulondoInfectious Diseases Research Collaboration, Kampala, Uganda.
Helen V HsiehIntellectual Ventures Laboratory, Bellevue, Washington.
Martin ChamaiInfectious Diseases Research Collaboration, Kampala, Uganda.
Bakar OdongoInfectious Diseases Research Collaboration, Kampala, Uganda.
Peter OlwochInfectious Diseases Research Collaboration, Kampala, Uganda.
Mayimuna NalubegaInfectious Diseases Research Collaboration, Kampala, Uganda.
Harriet OchokoruInfectious Diseases Research Collaboration, Kampala, Uganda.
Joseph KasoziInfectious Diseases Research Collaboration, Kampala, Uganda.
John AtegekaInfectious Diseases Research Collaboration, Kampala, Uganda.
Kevin P NicholsGlobal Health Laboratories, Bellevue, Washington.
Bernhard H WeiglGlobal Health Laboratories, Bellevue, Washington.
Bryan GreenhouseUniversity of California at San Francisco, San Francisco, California.
Infectious Diseases Research Collaboration · UGBellevue College · USIntellectual Ventures (United States) · USUniversity of California, San Francisco · US

Funding

Transmission ProjectU19AI089674 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHEW G DORSEY, MOSES Robert KAMYA · 2010 to 2026
$29.3M
Mentoring translational scientists in international infectious disease researchK24AI144048 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bryan R Greenhouse · 2019 to 2026
$1.6M
Translational Studies of Plasmodium Falciparum Infection DynamicsK23AI076614 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GREENHOUSE, BRYAN R · 2008 to 2012
$609k
NIAID NIH HHS K23 AI076614NIAID NIH HHS K24 AI144048NIAID NIH HHS U19 AI089674
6 · The paper itself

Abstract

Rapid diagnostic tests (RDTs) for Plasmodium falciparum commonly detect histidine-rich protein 2 (HRP-2), but HRP-2 deletions are increasingly recognized. We evaluated a prototype test detecting parasite lactate dehydrogenase (pLDH) and compared it to commercially available RDTs at a health facility in Uganda, using quantitative polymerase chain reaction as a gold standard. The prototype pLDH test had a high sensitivity for infections with at least 100 parasites/µL (98%), comparable to HRP-2, and greater than an existing pLDH RDT (89%). Specificity for the prototype test was 99.5%, which is greater than the HRP-2 tests (93-95%). Therefore, the prototype pLDH test may be an attractive alternative malaria diagnostic.

Indexed as

MalariaMalaria, FalciparumAntigens, ProtozoanDiagnostic Tests, RoutineHumansL-Lactate DehydrogenaseMicroscopyPlasmodium falciparumPolymerase Chain ReactionProtozoan ProteinsSensitivity and SpecificityUgandaAntigens, ProtozoanL-Lactate DehydrogenaseProtozoan Proteins

Identifiers

PMID35026727
PMCPMC8922488
OpenAlexW4205221104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.